The Antigen-Presenting Cell Function of Reed-Sternberg Cells

References

• Pichler W. J., Wyss-Coray T. T cells as antigen-presenting cells. Immunology Today 1994; 15: 312–315
   PubMedGoogle Scholar
• Linsley P., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med 1991; 173: 721–730
   PubMed Web of Science ®Google Scholar
• Koulova L., Clark E. A., Shu G., Dupont B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J. Exp. Med 1991; 173: 759–762
   PubMed Web of Science ®Google Scholar
• Gimmi C. D., Freeman G. J., Gribben J. G., Sugita K., Freedman A. S., Morimoto C., Nadler L. M. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 1991; 88: 6575–6579
   PubMed Web of Science ®Google Scholar
• Harding F. A., McArthur J. G., Gross J. A., Raulet D. H., Allison J. P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992; 356: 607–609
   PubMed Web of Science ®Google Scholar
• Lindstein T., June C. H., Ledbetter J. A., Stella G., Thompson C. B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244: 339–343
   PubMed Web of Science ®Google Scholar
• June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunology Today 1994; 15: 321–331
   PubMedGoogle Scholar
• Chen L., Ashe S., Brady W. A., Hellstrom I., Helstrom K. E., Ledbetter J. A., McGowan P., Linsley P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093–1102
   PubMed Web of Science ®Google Scholar
• Townsend S. E., Allison J. P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993; 259: 368–370
   PubMed Web of Science ®Google Scholar
• Yokochi T., Holly R. D., Clark E. A. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immunol 1982; 128: 823–827
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Freeman G. J., Rhynhart K., Nadler L. M. Selective induction of B7/BB1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol 1991; 137: 429–437
   PubMed Web of Science ®Google Scholar
• Young J. W., Koulova L., Soergel S. A., Clark E. A., Steinman R. M., Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest 1992; 90: 229–237
   PubMed Web of Science ®Google Scholar
• Vandenberghe P., Delabie J., de Boer M., De Wolf-Peeters C., Ceuppens J. L. Expression of B7/BB1 in lymphoid tissues: an immunohistochemical study. Int. Immunol 1993; 5: 317–321
   PubMed Web of Science ®Google Scholar
• Sansom D. M., Hall N. D. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol 1993; 23: 295–298
   PubMed Web of Science ®Google Scholar
• Azuma M., Yssel H., Phillips J. H., Spits H., Lanier L. L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med 1993; 177: 845–850
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Brady W., Umes M., Grosmaire L. S., Damle N. K., Ledbetter J. A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med 1991; 174: 561–569
   PubMed Web of Science ®Google Scholar
• Nickoloff B. J., Mitra R. S., Lee K., Turka L. A., Green J., Thompson C., Shimizu Y. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol 1993; 142: 1029–1040
   PubMed Web of Science ®Google Scholar
• Boussiotis V. A., Freeman G. J., Gribben J. G., Daley J., Gray G., Nadler L. M. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 1993; 90: 11059–11063
   PubMed Web of Science ®Google Scholar
• Hathcock K. S., Laszlo G., Dickler H. B., Bradshaw J., Linsley P., Hodes R. J. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993; 262: 905–907
   PubMed Web of Science ®Google Scholar
• Azuma M., Daisuke I., Yagita H., Okumura K., Phillips J. H., Lanier L. L., Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76–79
   PubMed Web of Science ®Google Scholar
• van Seventer G. A., Shimuzu Y., Horgan K. J., Ginther-Luce G. E., Webb D., Shaw S. Remote T cell costimulation with LFA-I/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated costimulation. Eur. J. Immunol 1991; 21: 1711–1718
   PubMed Web of Science ®Google Scholar
• van Seventer G. A., Bovini E., Hidehiro H., Conti A., Stringfellow S., June C. H., Shaw S. Costimulation of the T cell receptor/CD3-mediated activation of resting human CD4+ T cells by leukocyte function-associated antigen-1 ligand intercellular adhesion molecule-1 involves prolonged inositol phopholipid hydrolysis and sustained increase of intracellular calcium level. J. Immunol 1992; 149: 3872–3880
   PubMed Web of Science ®Google Scholar
• Kanner S. B., Damle N. K., Blake J., Aruffo A., Ledbetter J. A. CD2/LFA-3 ligation induce phospholipase Cγ1 tyrosine phosphorylation and regulate CD3 signalling. J. Immunol 1992; 148: 2023–2029
   PubMed Web of Science ®Google Scholar
• Pulvertaft R. J. V. Cellular associations in normal and abnormal lymphocytes. Proc. Roy. Soc. Med 1959; 52: 315–322
   PubMedGoogle Scholar
• Stuart A. E., Williams A. R. W., Habeshaw J. A. Rosetting and other reactions of the Reed-Sternberg cell. J. Path 1976; 122: 81–90
   Web of Science ®Google Scholar
• Sanders M. E., Makgoba M. W., Sussman E. H., Luce G. E. G., Cossman J., Shaw S. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428. Cancer Res 1988; 48: 37–40
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Hsu P. L. Lymphocyte functinal antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells. Am. J. Pathol 1990; 137: 563–574
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Bostick-Bruton F., Sauder D. N., Scala G., Diehl V. Neoplastic cells obtained fron Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures. J. Immunol 1983; 130: 2666–2670
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Cossman J., Diehl V., Volkman D. J. Antigen presentation by Hodgkin's disease cells. J. Immunol 1985; 135: 3568–3571
   PubMed Web of Science ®Google Scholar
• Hugh J., Poppema S. Immunophenotype of Reed-Sternberg cells. Int. Rev. Exp. Pathol 1992; 33: 81–114
   PubMedGoogle Scholar
• Ellis P. A., Hart D. N. J., Colls B. M., Nimmo J. C., MacDonald J. E., Angus H. B. Hodgkin's cells express a novel pattern of adhesion molecules. Clin. Exp. Immunol 1992; 90: 117–123
   PubMed Web of Science ®Google Scholar
• Poppema S. The nature of lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance Hodgkin's and in other types of Hodgkin's disease. Am. J. Pathol 1989; 135: 351–357
   PubMed Web of Science ®Google Scholar
• Schmid C., Isaacson P. G. Proliferating cells in Hodgkin's disease. Verh. Dtsch. Ges. Pathol 1992; 76: 151–154
   PubMedGoogle Scholar
• Delabie J., Ceuppens J. L., Vandenberghe P., de Boer M., Coorevits L., De Wolf-Peeters C. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 1993; 82: 2845–2852
   PubMed Web of Science ®Google Scholar
• Munro J. M., Freedman A. S., Aster J. C., Gribben J. G., Lee N. C., Rhynhart K. K., Banchereau J., Nadler L. M. In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells, and the malignant cells of Hodgkin's disease. Blood 1994; 83: 793–798
   PubMed Web of Science ®Google Scholar
• Delabie J., Moynihan M., Chan W. C., Weisenburger D. D. Expression of a second CD28 ligand. B7-2 by Reed-Sternberg cells, Manuscript in preparation
   Google Scholar
• Said J. W. The immunohistochemistry of Hodgkin's disease. Sem. Diagn. Pathol 1992; 9: 265–271
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Strickler J. G., Hu E., Warnke R. A., Sklar J. Immunoglobulin gene rearrangements in Hodgkin's disease. Hum. Pathol 1986; 17: 1009–1014
   PubMed Web of Science ®Google Scholar
• Sundeen J., Lipford E., Uppenkamp M., Sussman E., Wahl L., Raffeld M., Cossman J. Rearranged antigen receptor genes in Hodgkin's disease. Blood 1987; 70: 96–103
   PubMed Web of Science ®Google Scholar
• Brinker M. G. L., Poppema S., Buys C. H. C. M., Timens W., Osinga J., Visser L. Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease. Blood 1987; 70: 186–191
   PubMed Web of Science ®Google Scholar
• Drexler H. G. Recent results on the biology of Hogkin and Reed-Sternberg cells. II. Continuous cell lines. Leukemia and Lymphoma 1993; 9: 1–25
   PubMed Web of Science ®Google Scholar
• Mason D. Y., Banks P. M., Chan J., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Grogan T. M., Harris N. L., Isaacson P. G., Jaffe E. S., Knowles D. M., Muller-Hermelink H. K., Pileri S., Ralfkiaer E., Stein H., Warnke R. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathologic entity. Am. J. Surg. Pathol 1994; 18: 526–530
   PubMed Web of Science ®Google Scholar
• Delabie J., Tierens A., Wu G., Weisenburger D. D., Chan W. C. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994, in press
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314: 537–539
   PubMed Web of Science ®Google Scholar
• Krieger J. I., Chestnut R. W., Grey H. M. Capacity of B cells to function as stimulators of a primary mixed leucocyte reaction. J. Immunol 1986; 137: 3117–3123
   PubMed Web of Science ®Google Scholar
• McKenzie D. Alloantigen presentation by B cells. Requirement for IL-1 and IL-6. J. Immunol 1988; 141: 2907–2911
   PubMed Web of Science ®Google Scholar
• Houghton A. N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med 1994; 180: 1–4
   PubMed Web of Science ®Google Scholar
• Maggi E., Parronchi P., Macchia D., Bellesi G., Romagnani S. High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease. Blood 1988; 71: 1503–1506
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Herbst H., Niedobitek G., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810–816
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Murray R. J., Wang D., Young L., Wang F., Rowe M., Kieff E., Rickinson A. B. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. J. Virol 1988; 62: 3747–3757
   PubMed Web of Science ®Google Scholar
• Romagnani S., Maggi E., Parronchi P., Macchia D., Del Prete G. F., Rossi-Ferrini P. L., Ricci M., Moreta L. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2. Int. J. Cancer 1986; 37: 343–349
   PubMed Web of Science ®Google Scholar
• Maggi E., Parronchi P., Macchia D., Piccinni M.-P., Simonelli C., Romagnani S. Role of T cells in the pathogenesis of Hodgkin's disease. Int. Rev. Exp. Pathol 1992; 33: 141–164
   PubMedGoogle Scholar
• Poppema S., Visser L. Absence of HLA Class I expression by Reed-Sternberg cells. Am. J. Pathol 1994; 145: 37–41
   Google Scholar